Progress in Venous Thromboembolism Research
A special issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: 31 October 2025 | Viewed by 1158
Special Issue Editor
Interests: hypertension; atrial fibrillation; heart failure; venous thromboembolism (deep vein thrombosis, pulmonary thromboembolism); thrombophilias
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Venous thromboembolism (VTE) is the third most frequent cardiovascular disease after myocardial infarction and ischemic stroke. The burden of disease is enormous, considering the risk of death and complications such as recurrence, post-thrombotic syndrome, chronic thromboembolic pulmonary disease, or bleeding while on anticoagulants.
Despite these, VTE is a preventable disease. Progress in reducing the disease burden both through prevention and treatment has been made during recent years. The development of risk assessment models allows for a better selection of patients for prophylaxis. Choosing the appropriate medications, doses and duration of prophylaxis are very important steps in patient management for both inpatients and outpatients.
Improvement of the diagnosis algorithm will decrease the costs and the number of misdiagnosed cases.
Progress in treatment strategies (medical and interventional) will minimize mortality and morbidity. New anticoagulant drugs targeting factor XI are being evaluated in phase 3 clinical trials in people with atrial fibrillation. Their future use in patients with VTE will mark a big step forward that may improve outcomes in this population.
Considering the above, I propose this Special Issue on the Progress in Venous Thromboembolism Research, which will focus on progress in prevention, diagnosis, treatment, and prevention of complications.
Dr. Mihaela Hostiuc
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- venous thromboembolism
- cardiovascular disease
- post-thrombotic syndrome
- chronic thromboembolic pulmonary disease
- prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
